Trial Profile
The Effects of Statin Therapy on Coronary Flow Reserve and Inflammatory Markers in HIV-Positive Patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Rosuvastatin (Primary)
- Indications Cardiovascular disorders; HIV infections
- Focus Therapeutic Use
- 03 Oct 2018 Status changed from recruiting to completed.
- 17 Jun 2015 Status changed from not yet recruiting to recruiting, as reported by ClinicalTrials.gov.
- 11 Sep 2014 New trial record